Tuesday 20th June 2023 |
Text too small? |
Auckland, New Zealand, 20 June 2023 - Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation for the ASX’s CEO Connect webinar to be held later today.
There is no new material information contained within the presentation.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
Hayden Brown
Head of Capital Markets & Investor Relations
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073
Dan Adolph
Senior Communications & Investor Relations Manager
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050
Authorised by Raelene Leonard, General Counsel and Company Secretary.
No comments yet
VCT announces conditional sale agreement for its LPG assets
GEN - Equifax reaffirms General Finance Limited's BB rating
General Capital Subsidiary General Finance Market Update
CHATHAM ADVISES EXTENDED CLOSING DATE OF 9 AUGUST FOR SPP
Acceleration of expressway will be transformative for Northland economy says EMA
The Warehouse Group - Proposed Scheme of Arrangement
The Warehouse Group - Proposed Scheme of Arrangement
Winton announces timing of its Annual Results
Fletcher Building Announces Director Appointment
Meridian issues new demand response exercise notice to NZAS